...
首页> 外文期刊>Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists >Initial experience with abdominal aneurysm repair using the E-vita abdominal stent-graft: a single-center study.
【24h】

Initial experience with abdominal aneurysm repair using the E-vita abdominal stent-graft: a single-center study.

机译:使用E-vita腹部支架移植物进行腹部动脉瘤修复的初步经验:单中心研究。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate the feasibility and midterm results of a new stent-graft for infrarenal endovascular aneurysm repair (EVAR) in a non-selected population. METHODS: Nineteen consecutive patients (19 men; mean age 70 years, range 58-87) who presented within an 8-month period with abdominal aortic aneurysms (AAA) suitable for EVAR were treated with the new E-vita abdominal stent-graft. Most of the patients (13, 68%) were ASA grade 3 or higher; the maximum AAA diameter was 57 mm (40-75), and hostile necks were present in a third and tortuous iliac arteries in half. Most of the cases (18, 95%) were elective; 1 was performed for a contained rupture. Seventeen procedures were primary implantations and 2 were secondary repairs of failing endografts. RESULTS: All stent-grafts were implanted at the intended position; no conversions to open surgery were necessary and no type I endoleak was noted. Fifteen bifurcated and 4 straight stent-grafts were implanted; the majority of the vascular accesses (29/35, 83%) were percutaneous. There was no 30-day mortality. In the mean 10-month follow-up (range 4-17), no stent fractures, migrations, or secondary endoleaks were noted. Aneurysm diameter was reduced in 8 (42%) and remained unchanged in 11 (58%) patients. One patient required open surgery at 1 year for thrombotic occlusion of the stent-graft. Two octogenarian patients died during follow-up. CONCLUSION: The E-vita abdominal stent-graft appears safe and effective in this initial midterm clinical experience. This device appears especially suitable to challenging aneurysm anatomy, such as severely angulated necks or tortuous and dilated iliac arteries.
机译:目的:评估在非选定人群中用于肾内血管内动脉瘤修复(EVAR)的新型支架移植物的可行性和中期结果。方法:采用新型E-vita腹部支架移植物治疗了连续8个月内出现适合EVAR的腹主动脉瘤(AAA)的19例患者(19名男性,平均年龄70岁,范围58-87)。大多数患者(13%,68%)是ASA 3级或更高。最大AAA直径为57毫米(40-75),敌对颈位于第三条,曲动脉一半。大多数情况(18%,95%)是选修;进行1次封闭破裂。十七次手术为一次植入,二次为失败的内移植修复。结果:所有支架植入物均植入了预定位置。无需转换为开放手术,也没有发现I型内漏。植入了15个分叉的和4个笔直的支架植入物;大多数血管通路(29/35,83%)是经皮的。没有30天的死亡率。在平均10个月的随访中(范围4-17),未发现支架破裂,移位或继发内渗。 8例(42%)的动脉瘤直径减少,11例(58%)的患者动脉瘤直径未改变。一名患者需要在1年时进行开放手术,以使支架移植物血栓闭塞。两名八岁患者在随访期间死亡。结论:在最初的中期临床经验中,E-vita腹部支架移植物似乎是安全有效的。该装置似乎特别适合于挑战性的动脉瘤解剖结构,例如颈部严重弯曲或or曲和扩张的动脉。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号